Quest Diagnostics Incorporated (DGX) has a consensus analyst rating of Hold, based on 34 analysts covering the stock. Of those, 13 recommend buying, 18 recommend holding, and 3 recommend selling.
The analyst consensus price target for DGX is $215.10, representing a +10.8% upside from the current price of $194.16. Price targets range from a low of $200.00 to a high of $235.00.
